Du F - Search Results

1

Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study.

Kang Y, Yan Q, Fu Q, Wang R, Dai M, Du F, Dai Q, Ye P, Wu C, Lu L, Bao C. Kang Y, et al. Among authors: du f. Arthritis Res Ther. 2020 Mar 30;22(1):65. doi: 10.1186/s13075-020-02154-7. Arthritis Res Ther. 2020. PMID: 32228698 Free PMC article.

2

T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis.

Du F, Lü LJ, Fu Q, Dai M, Teng JL, Fan W, Chen SL, Ye P, Shen N, Huang XF, Qian J, Bao CD. Du F, et al. Arthritis Res Ther. 2008;10(6):R136. doi: 10.1186/ar2554. Epub 2008 Nov 19. Arthritis Res Ther. 2008. PMID: 19019215 Free PMC article.

3

Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.

Lu LJ, Bao CD, Dai M, Teng JL, Fan W, Du F, Yang NP, Zhao YH, Chen ZW, Xu JH, He PG, Wu HX, Tao Y, Zhang MJ, Han XH, Li XF, Gu JR, Li JH, Yu H. Lu LJ, et al. Among authors: du f. Arthritis Rheum. 2009 Jul 15;61(7):979-87. doi: 10.1002/art.24643. Arthritis Rheum. 2009. PMID: 19565542 Free article. Clinical Trial.

4

T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro.

Du F, Lü LJ, Teng JL, Shen N, Ye P, Bao CD. Du F, et al. Int Immunopharmacol. 2012 May;13(1):54-60. doi: 10.1016/j.intimp.2012.03.003. Epub 2012 Mar 21. Int Immunopharmacol. 2012. PMID: 22446297 Clinical Trial.

5

Deoxycytidine kinase promotes the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.

Fan W, Zhou ZY, Huang XF, Bao CD, Du F. Fan W, et al. Among authors: du f. Int J Clin Exp Pathol. 2013 Nov 15;6(12):2733-44. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24294360 Free PMC article.

6

Prevention of immune nephritis by the small molecular weight immunomodulator iguratimod in MRL/lpr mice.

Yan Q, Du F, Huang X, Fu Q, Chen S, Dai D, Bao C. Yan Q, et al. Among authors: du f. PLoS One. 2014 Oct 1;9(10):e108273. doi: 10.1371/journal.pone.0108273. eCollection 2014. PLoS One. 2014. PMID: 25271634 Free PMC article.

7

Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis.

Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, Fu Q, Guo Q, Yan Q, Zhang X, Bao C. Ye Y, et al. Among authors: du f. Arthritis Res Ther. 2019 Apr 11;21(1):92. doi: 10.1186/s13075-019-1874-2. Arthritis Res Ther. 2019. PMID: 30971291 Free PMC article.

8

Melatonin prevents endothelial dysfunction in SLE by activating the nuclear receptor retinoic acid-related orphan receptor-α.

Huang H, Liu X, Chen D, Lu Y, Li J, Du F, Zhang C, Lu L. Huang H, et al. Among authors: du f. Int Immunopharmacol. 2020 Jun;83:106365. doi: 10.1016/j.intimp.2020.106365. Epub 2020 Mar 12. Int Immunopharmacol. 2020. PMID: 32172204

9

Corrigendum to "Melatonin prevents endothelial dysfunction in SLE by activating the nuclear receptor retinoic acid-related orphan receptor-α" [Int. Immunopharmacol. 83 (2020) 106365].

Huang H, Liu X, Chen D, Lu Y, Li J, Du F, Zhang C, Lu L. Huang H, et al. Among authors: du f. Int Immunopharmacol. 2020 Sep;86:106817. doi: 10.1016/j.intimp.2020.106817. Epub 2020 Jul 28. Int Immunopharmacol. 2020. PMID: 32736997 No abstract available.

10

Cutaneous ulceration and digital gangrene in an anti-MDA5-positive overlap myositis.

Xu A, Lv X, Du F, Dai M. Xu A, et al. Among authors: du f. Rheumatology (Oxford). 2021 Dec 1;60(12):5880-5881. doi: 10.1093/rheumatology/keab284. Rheumatology (Oxford). 2021. PMID: 33752240 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,699 results

Search Page

Filters